Thomas A. Medsger

University of Pittsburgh

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial”.

Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial

American Journal of Respiratory and Critical Care Medicine(2021)10.1164/rccm.202009-3481oc

N/A

3.9DataRank · unranked

185 citations

David B. Badesch, Lorinda Chung, Robyn T. Domsic, Thomas A. Medsger, Ashley Pinckney +14 more

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

Arthritis & Rheumatism(1988)10.1002/art.1780310302

N/A

1.5DataRank · unranked

19883 citations

Steven M. Edworthy, Daniel A. Bloch, Dennis J. McShane, James F. Fries, Norman S. Cooper +14 more

Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee

Arthritis & Rheumatism(1986)10.1002/art.1780290816

N/A

1.3DataRank · unranked

6746 citations

E. Asch, Daniel A. Bloch, G. Bole, D. Borenstein, K. Brandt +41 more

Mortality in systemic sclerosis: An international meta-analysis of individual patient data

The American Journal of Medicine(2005)10.1016/j.amjmed.2004.04.031

N/A

0.912DataRank · unranked

437 citations

Panayiotis G. Vlachoyiannopoulos, Thomas A. Medsger, Mary Lucas, Clement J. Michet, Masataka Kuwana +14 more

Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis

Annals of the Rheumatic Diseases(2021)10.1136/annrheumdis-2021-221050

N/A

0DataRank · unranked

40 citations

Ludivine Renaud, Naoko Takamura, Kip D. Zimmerman, Willian A. da Silveira, Paula S. Ramos +9 more

Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design

Lara D. Veeken(2021)10.1093/rheumatology/keab075

N/A

0DataRank · unranked

20 citations

Shiyao Gao, Maureen Laffoon, Stephen R. Wisniewski, Yuqing Zhang, Virginia Steen +3 more

A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials

Lara D. Veeken(2022)10.1093/rheumatology/keac501

N/A

0DataRank · unranked

7 citations

Thomas A. Medsger, Shiyao Gao, Maureen Laffoon, Suiyuan Huang, Stephen R. Wisniewski +5 more